Romiplostim (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Romiplostim" in Italian language version.

refsWebsite

Global rank Italian rank

799^th place

22^nd place

2^nd place

7^th place

4^th place

9^th place

719^th place

799^th place

399^th place

1,563^rd place

68^th place

57^th place

5^th place

26^th place

4,963^rd place

325^th place

doi.org

dx.doi.org

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial, vol. 371, febbraio 2008, DOI:10.1016/S0140-6736(08)60203-2, PMID 18242413.
Romiplostim: a novel thrombopoiesis-stimulating agent, vol. 66, 2009, DOI:10.2146/ajhp080524, PMID 19386944.
Akane Chiba, Nanami Kawabata, Masaru Yamaguchi, Shinji Tokonami e Ikuo Kashiwakura, Regulation of Antioxidant Stress-Responsive Transcription Factor Nrf2 Target Gene in the Reduction of Radiation Damage by the Thrombocytopenia Drug Romiplostim, in Biological and Pharmaceutical Bulletin, vol. 43, n. 12, Pharmaceutical Society of Japan, 1º dicembre 2020, pp. 1876–1883, DOI:10.1248/bpb.b20-00442, ISSN 0918-6158 (WC · ACNP).

drugs.com

drugs.com, https://www.drugs.com/nda/romiplostim_080312.html Titolo mancante per url url (aiuto). URL consultato il 4 novembre 2008.

europa.eu

ema.europa.eu

European Medicines Agency, su European Medicines Agency, 17 settembre 2018. URL consultato l'8 ottobre 2022.

medscape.com

reference.medscape.com

Nplate (romiplostim) dosing, indications, interactions, adverse effects, and more, su Medscape Drugs & Diseases - Comprehensive peer-reviewed medical condition, surgery, and clinical procedure articles with symptoms, diagnosis, staging, treatment, drugs and medications, prognosis, follow-up, and pictures, 12 settembre 2022. URL consultato il 7 ottobre 2022.

nih.gov

ncbi.nlm.nih.gov

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial, vol. 371, febbraio 2008, DOI:10.1016/S0140-6736(08)60203-2, PMID 18242413.
Romiplostim: a novel thrombopoiesis-stimulating agent, vol. 66, 2009, DOI:10.2146/ajhp080524, PMID 19386944.

oadoi.org

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial, vol. 371, febbraio 2008, DOI:10.1016/S0140-6736(08)60203-2, PMID 18242413.
Romiplostim: a novel thrombopoiesis-stimulating agent, vol. 66, 2009, DOI:10.2146/ajhp080524, PMID 19386944.
Akane Chiba, Nanami Kawabata, Masaru Yamaguchi, Shinji Tokonami e Ikuo Kashiwakura, Regulation of Antioxidant Stress-Responsive Transcription Factor Nrf2 Target Gene in the Reduction of Radiation Damage by the Thrombocytopenia Drug Romiplostim, in Biological and Pharmaceutical Bulletin, vol. 43, n. 12, Pharmaceutical Society of Japan, 1º dicembre 2020, pp. 1876–1883, DOI:10.1248/bpb.b20-00442, ISSN 0918-6158 (WC · ACNP).

unibo.it

acnpsearch.unibo.it

Akane Chiba, Nanami Kawabata, Masaru Yamaguchi, Shinji Tokonami e Ikuo Kashiwakura, Regulation of Antioxidant Stress-Responsive Transcription Factor Nrf2 Target Gene in the Reduction of Radiation Damage by the Thrombocytopenia Drug Romiplostim, in Biological and Pharmaceutical Bulletin, vol. 43, n. 12, Pharmaceutical Society of Japan, 1º dicembre 2020, pp. 1876–1883, DOI:10.1248/bpb.b20-00442, ISSN 0918-6158 (WC · ACNP).

worldcat.org

Akane Chiba, Nanami Kawabata, Masaru Yamaguchi, Shinji Tokonami e Ikuo Kashiwakura, Regulation of Antioxidant Stress-Responsive Transcription Factor Nrf2 Target Gene in the Reduction of Radiation Damage by the Thrombocytopenia Drug Romiplostim, in Biological and Pharmaceutical Bulletin, vol. 43, n. 12, Pharmaceutical Society of Japan, 1º dicembre 2020, pp. 1876–1883, DOI:10.1248/bpb.b20-00442, ISSN 0918-6158 (WC · ACNP).